CE Marking on Medical Devices What Recent EU MDR Updates Mean for UK Exporters
CE marking is the regulatory gateway for placing medical devices on the European market. It confirms that a device meets the safety, performance, and regulatory requirements established under EU law and can be legally sold across the European Economic Area (EEA).
For manufacturers, importers, and distributors, CE marking is not just a symbol on packaging. It represents a structured regulatory process involving classification, documentation, risk management, and ongoing monitoring of the device throughout its lifecycle.
This guide explains how CE marking for medical devices works, the steps required to obtain it, and what manufacturers must do to remain compliant.
What CE Marking Means for Medical Devices
CE marking on a medical device indicates that the manufacturer has demonstrated conformity with the requirements of the EU Medical Device Regulation (EU) 2017/745 (MDR) or the In Vitro Diagnostic Regulation (EU) 2017/746 (IVDR), depending on the device type.
These regulations set the legal framework for placing medical devices on the EU market and ensure that products meet strict General Safety and Performance Requirements (GSPRs) before they reach patients or healthcare professionals.
Once a device has successfully completed the conformity assessment process and the manufacturer has signed the EU Declaration of Conformity, the CE mark can be applied to the product. This allows the device to be marketed across EU and EEA countries.
Which Medical Devices Require CE Marking
CE marking is mandatory for all medical devices placed on the EU market, regardless of where the manufacturer is based.
This includes:
- EU-based manufacturers
- Non-EU manufacturers exporting devices to the EU
- Importers bringing devices into the EU market
- Private-label manufacturers placing devices under their own brand
If a manufacturer is located outside the EU, they must appoint an EU Authorised Representative (EU AR). This representative acts as the official contact point for EU authorities and ensures regulatory documentation is accessible within the EU.
Medical Device Classification Under EU MDR
The conformity assessment route for CE marking depends on the risk classification of the device.
Medical devices are classified into four main categories under the MDR:
Class | Risk Level | Examples |
Class I | Low risk | Bandages, stethoscopes |
Class IIa | Medium risk | Infusion pumps |
Class IIb | Medium-high risk | Ventilators |
Class III | High risk | Implantable pacemakers |
The classification rules are defined in Annex VIII of the MDR and determine whether the device requires review by a Notified Body.
Most Class IIa, IIb, and III devices require Notified Body assessment before CE marking can be granted.
Low-risk Class I devices are typically self-certified by the manufacturer unless they are sterile, measuring devices, or reusable surgical instruments.
Steps to Obtain CE Marking for a Medical Device
Achieving CE marking involves several structured stages.
1. Determine Whether Your Product Is a Medical Device
The first step is confirming whether your product qualifies as a medical device under MDR. A medical device is any instrument, software, or material intended for medical purposes such as diagnosis, prevention, monitoring, treatment, or alleviation of disease.
2. Classify the Device
The manufacturer must determine the correct risk classification based on intended use, duration of contact, and potential risk to patients.
3. Implement a Quality Management System
Manufacturers must implement a compliant Quality Management System (QMS). In most cases this is aligned with ISO 13485, the international standard for medical device quality systems.
4. Prepare Technical Documentation
The technical file must demonstrate that the device meets the MDR General Safety and Performance Requirements.
Typical documentation includes:
- Device description and specifications
- Risk management file
- Clinical evaluation or clinical investigation data
- Design and manufacturing information
- Labelling and instructions for use
- Post-market surveillance plan
5. Conformity Assessment
For most devices, a Notified Body evaluates the device and the manufacturer’s quality system.
Class I devices generally follow self-certification unless they fall into special sub-categories.
6. Issue the EU Declaration of Conformity
After successful conformity assessment, the manufacturer signs the EU Declaration of Conformity, confirming the device complies with MDR requirements.
7. Apply the CE Mark
Once the Declaration of Conformity is completed, the CE mark can be affixed to the device, packaging, and documentation.
Post-Market Requirements After CE Marking
Obtaining CE marking is not the end of the regulatory process.
Manufacturers must continue to meet ongoing obligations, including:
- Post-market surveillance (PMS)
- Vigilance reporting for incidents and safety issues
- Periodic safety updates
- Device traceability using Unique Device Identification (UDI)
Manufacturers must also maintain technical documentation and provide it to authorities when requested.
CE Marking and Device Registration
Before a device can be marketed in the EU, manufacturers and their devices must be registered in the EUDAMED database.
EUDAMED improves traceability and transparency by storing information on:
- manufacturers and authorised representatives
- device identifiers
- clinical investigations
- vigilance reports
Registration helps regulators monitor safety issues and coordinate responses across the EU.
CE Marking and the UK Market
Since Brexit, the UK has developed its own regulatory framework for medical devices.
Great Britain
Great Britain (England, Scotland, and Wales) uses the UK Medical Devices Regulations 2002 (UK MDR).
However, CE-marked devices can still be placed on the Great Britain market under extended transitional timelines.
Under current rules:
- Devices compliant with the old EU directives (MDD or AIMDD) can be placed on the market until the earlier of their certificate expiry or 30 June 2028.
- Devices compliant with EU MDR or IVDR can be placed on the market until 30 June 2030.
Manufacturers may also obtain UKCA marking, which demonstrates conformity with UK MDR requirements.
Northern Ireland
Northern Ireland continues to follow EU device rules under the Northern Ireland Protocol.
Devices placed on the Northern Ireland market must carry the CE mark.
If conformity assessment is conducted by a UK Approved Body rather than an EU Notified Body, the device must carry both CE and UKNI marking.
Common CE Marking Mistakes for Medical Devices
Several common compliance mistakes can delay or prevent CE marking.
These include:
- Incorrect device classification
- Incomplete clinical evaluation
- Missing technical documentation
- Poor risk management documentation
- Inadequate post-market surveillance planning
Because MDR requirements are more demanding than previous directives, manufacturers often underestimate the amount of documentation required.
Final Thoughts
CE marking is essential for selling medical devices in the European Union. It confirms that a device meets strict regulatory standards for safety and performance and that the manufacturer has completed the required conformity assessment process.
For manufacturers operating internationally, understanding the relationship between EU MDR requirements and the evolving UK regulatory framework is critical to maintaining market access.
By planning the CE marking process early and maintaining strong technical documentation, manufacturers can avoid regulatory delays and bring compliant medical devices to market successfully.
If your business needs support navigating medical device compliance, Euverify can help. From EU Authorised Representative services to regulatory guidance and documentation support, our team helps manufacturers meet EU and UK requirements and bring compliant medical devices to market with confidence.
Frequently Asked Questions
Most devices require CE marking before being placed on the EU market. The conformity assessment process depends on the device classification under MDR.
Manufacturers issue the CE marking after completing the conformity assessment process. For higher-risk devices, a Notified Body must review the documentation before CE marking can be applied.
Yes. Manufacturers located outside the EU must appoint an EU Authorised Representative to place medical devices on the EU market.
Yes. Under current transitional arrangements, CE-marked medical devices can be placed on the Great Britain market until 2028 or 2030 depending on the device type.
Authorities may remove the product from the market, impose penalties, or require corrective actions.